Real-time enrollment status for this geographic atrophy (ga) clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:01 PM UTC
| NCT Number | NCT06659445 |
| Recruiting Status | Recruiting |
| Condition | Geographic Atrophy (GA) |
| Phase | PHASE2 |
| Target Enrollment | 324 participants |
| Active Locations | 56 sites in the US |
| Sponsor | ONL Therapeutics |
| Last Updated on CT.gov | September 10, 2026 (Sep 10, 2026) |
As of October 12, 2026: Clinical trial NCT06659445 is currently recruiting participants. This phase2 study for geographic atrophy (ga) is actively seeking new participants at 56 locations across the United States. The study is sponsored by ONL Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06659445 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 56 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06659445 was last updated Sep 10, 2026 (September 10, 2026). HelloStudys verifies this status automatically.